SOFOSBUVIR in Chinese translation

• sofosbuvir
• 索非布韦
• 索氟布韦

Examples of using Sofosbuvir in English and their translations into Chinese

Sofosbuvir was reasonably well tolerated: adverse events were common(81%), but serious adverse events(17%) and treatment discontinuations(8%) were uncommon.
Sofosbuvir被合理地容忍了：不良事件是常见的(81%)，但严重的不良事件(17%)和治疗不连续性(8%)是不常见的。

Sofosbuvir is a potent direct-acting antiviral therapy against HCV, but concerns about potential kidney toxicity have been raised, particularly in patients with CKD.
Sofosbuvir是一种针对丙肝病毒的有效的直接抗病毒药物治疗，但是对潜在的肾脏毒性的担忧已经增加，尤其是在CKD患者身上。

But using sofosbuvir at Gilead's price, in combination with another DAA, daclatasvir, would cost about $12,000 for the 12-week treatment.
但若以吉利德提供的价格使用索非布韦，再加上另一种直接抗病毒药物达卡他韦（daclatasvir），12周的治疗费用约为1.2万美元。

A 12-week Sofosbuvir course, one of the treatments not covered by primary insurance, costs 69,600 yuan($ 9700 USD).
而为期12周的索华迪（Sofosbuvir）治疗，就是未涵盖在基本保险内的医治丙型肝炎的方案之一，费用为69,600元人民币（约9,700美元）。

Sofosbuvir+ velpatasvir as the first combination therapy to treat all six types of hepatitis C(WHO is currently updating its treatment recommendations for hepatitis C).
索非布韦+维帕他韦作为治疗所有六种类型丙型肝炎的第一种联合疗法（世卫组织目前正在更新关于丙型肝炎的治疗建议）；.

A 12-week course of Sofosbuvir, one of the treatments not covered by basic insurance, costs 69,600 yuan($9700 USD).
而为期12周的索华迪（Sofosbuvir）治疗，就是未涵盖在基本保险内的医治丙型肝炎的方案之一，费用为69,600元人民币（约9,700美元）。

The US Food and Drug Administration on April 7 approved supplemental applications for sofosbuvir and ledipasvir and sofosbuvir(Harvoni) to treat HCV in children ages 12 to 17.
年4月7日，美国食品和药物管理局批准了Sovaldi（sofosbuvir）和Harvoni（ledipasvir和sofosbuvir）在12至17岁儿童中治疗丙型肝炎病毒（HCV）的补充申请。

Treating all of these people with a sofosbuvir-based regimen would cost more than the entire 2014 budget for the Paris public hospital system- just for sofosbuvir.
采用索氟布韦的疗程治疗所有这些患者的费用将比巴黎公共医院系统2014年全年的预算还要高--而这仅是索氟布韦的部分。

Sofosbuvir is pregnancy category B.
Sofosbuvir对妊娠的安全性是B级。

All 20 patients completed six weeks of Sofosbuvir and Ledipasvir without Ribavirin.
所有的20名患者服用了6周的sofosbuvir和ledipasvir没有利巴韦林的药物。

MyHep All medication is a combination of sofosbuvir and velpatasvir.
MyHep所有药物都是sofosbuvir和velpatasvir的组合。

For some people, sofosbuvir will be the first interferon-free hepatitis C treatment option.
对于一些人来说，sofosbuvir索非布韦将是第一个无干扰素丙型肝炎治疗方案。

Patients should not take Harvoni with other products that contain sofosbuvir(e.g. Sovaldi).
不建议HARVONI与其他含sofosbuvir(SOVALDI®)产品使用。

Key patents on sofosbuvir have already been rejected in Egypt and India.
索菲布韦的关键专利申请，也已经被埃及和印度驳回。

Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus(HCV) antiviral agents.
Ledipasvir和sofosbuvir是2种丙型肝炎病毒（HCV）抗病毒药物的组合。

Harvoni is a two-drug fixed-dose combination product containing 90mg of ledipasvir and 400mg sofosbuvir.
HARVONI是一种两药固定剂量复方产品，在单一片中含90mgledipasvir和400mgsofosbuvir。

The following is a list of possible side-effects that may occur in medicines that contain Sofosbuvir.
以下是含有Sofosbuvir的药物可能出现的副作用列表：.

Ledipasvir& Sofosbuvir is a combination of 2 hepatitis C virus(HCV) antiviral agents.
Ledipasvir和sofosbuvir是2种丙型肝炎病毒（HCV）抗病毒药物的组合。

Among middle-income countries, the price for a three-month treatment of sofosbuvir and daclatasvir varies greatly.
在中等收入国家，用索非布韦（sofosbuvir）和达卡他韦（daclatasvir）治疗三个月的价格差别很大。

Fact: The same amount of sofosbuvir can be produced- profitably- for US$ 101.
真相：同样数量的索氟布韦以101美元即可获利生产。